| Pharmaceutical Information |
| Drug Name |
Tropisetron |
| Drug ID |
BADD_D02304 |
| Description |
Tropisetron is an indole derivative with antiemetic activity. As a selective serotonin receptor antagonist, tropisetron competitively blocks the action of serotonin at 5HT3 receptors, resulting in suppression of chemotherapy- and radiotherapy-induced nausea and vomiting.
Tropisetron appears to be well tolerated with the most frequently reported adverse effect being headache. Extrapyramidal side effects are rare upon using tropisetron. |
| Indications and Usage |
For the prevention of nausea and vomiting induced by cytotoxic therapy and postoperative. |
| Marketing Status |
approved; investigational |
| ATC Code |
A04AA03 |
| DrugBank ID |
DB11699
|
| KEGG ID |
D02130
|
| MeSH ID |
D000077526
|
| PubChem ID |
656665
|
| TTD Drug ID |
D0K0KH
|
| NDC Product Code |
Not Available |
| UNII |
6I819NIK1W
|
| Synonyms |
Tropisetron | Navoban | (3 alpha-Tropanyl)-1H-indole-3-carboxylic Acid Ester | Indole-3-carboxylic Acid Tropine Ester | Indole 3 carboxylic Acid Tropine Ester | ICS 205-930 | ICS 205 930 | ICS 205930 | ICS-205-930 | ICS-205930 | Tropisetron Hydrochloride |
|
| Chemical Information |
| Molecular Formula |
C17H20N2O2 |
| CAS Registry Number |
89565-68-4 |
| SMILES |
CN1C2CCC1CC(C2)OC(=O)C3=CNC4=CC=CC=C43 |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
|
